Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about OrsoBio aggregated by PharmaCompass.com.

    Client Virtual Booth

    ORSOBIO

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    OrsoBio
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Palo Alto, CA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://orsobio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/orsobio/about/
    Twitter
    Twitter
    https://twitter.com/OrsoBio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Lilly backs OrsoBio's $60M Series A for PhII trials in obesity and NASH
    Lilly backs OrsoBio's $60M Series A for PhII trials in obesity and NASH

    https://endpts.com/lilly-backs-orsobios-60m-series-a-for-phii-trials-in-obesity-and-nash/

    Kyle LaHucik ENDPTS
    08 Nov 2023
    Share Share
    OrsoBio Announces $60M Series A Financing
    OrsoBio Announces $60M Series A Financing

    https://www.businesswire.com/news/home/20231107979704/en

    BUSINESSWIRE
    07 Nov 2023
    Share Share
    OrsoBio to Present Phase 1 Data for Liver-Targeted LXR Inverse Agonist TLC-2716
    OrsoBio to Present Phase 1 Data for Liver-Targeted LXR Inverse Agonist TLC-2716

    https://www.businesswire.com/news/home/20231106130144/en

    BUSINESSWIRE
    06 Nov 2023
    Share Share
    OrsoBio to Present Phase 1 Data for the TLC-6740
    OrsoBio to Present Phase 1 Data for the TLC-6740

    https://www.businesswire.com/news/home/20231016944576/en

    BUSINESSWIRE
    16 Oct 2023
    Share Share
    OrsoBio Announces Phase 1 Trial of TLC-6740, a Mitochondrial Protonophore
    OrsoBio Announces Phase 1 Trial of TLC-6740, a Mitochondrial Protonophore

    https://www.businesswire.com/news/home/20230605005177/en

    BUSINESSWIRE
    05 Jun 2023
    Share Share
    OrsoBio Announces First Patient Dosed in Phase 2 Trial of TLC-3595
    OrsoBio Announces First Patient Dosed in Phase 2 Trial of TLC-3595

    https://www.businesswire.com/news/home/20230320005028/en

    BUSINESSWIRE
    20 Mar 2023
    Share Share
    OrsoBio Launches to Develop Novel Therapies for Severe Metabolic Disorders
    OrsoBio Launches to Develop Novel Therapies for Severe Metabolic Disorders

    https://www.businesswire.com/news/home/20221101005427/en

    BUSINESSWIRE
    01 Nov 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search